|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Investments at fair value | ||||||||||||||||
| Non-controlled/non-affiliated investments | ||||||||||||||||
| Non-controlled/affiliated investments | ||||||||||||||||
| Total investments at fair value | ||||||||||||||||
| Cash and Cash Equivalent | ||||||||||||||||
| Interest receivable from non-controlled/non-affiliated investments | ||||||||||||||||
| Non-controlled/non-affiliated investments | ||||||||||||||||
| Non-controlled/affiliated investments | ||||||||||||||||
| Receivable from broker | ||||||||||||||||
| Deferred financing costs | ||||||||||||||||
| Receivable for investments | ||||||||||||||||
| Receivable for shares sold | ||||||||||||||||
| Derivative assets at fair value (Note 6) | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES | ||||||||||||||||
| Debt (net of unamortized debt issuance costs of $51,435 and $39,900, respectively) | ||||||||||||||||
| Payable for investments | ||||||||||||||||
| Due to affiliates | ||||||||||||||||
| Management fees payable (Note 3) | ||||||||||||||||
| Income based incentive fees payable (Note 3) | ||||||||||||||||
| Capital gains based incentive fees payable (Note 3) | ||||||||||||||||
| Interest payable | ||||||||||||||||
| Derivative liabilities at fair value (Note 6) | ||||||||||||||||
| Distribution payable | ||||||||||||||||
| Board of Trustees’ fees payable | ||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| NET ASSETS | ||||||||||||||||
| Common Shares, $0.001 par value (unlimited shares authorized; 232,652,003 and 231,969,058 shares issued and outstanding, respectively) | ||||||||||||||||
| Additional paid in capital | ||||||||||||||||
| Distributable earnings (loss) | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and net assets | ||||||||||||||||
| NET ASSET VALUE PER SHARE (in usd per share) | ||||||||||||||||
Loading...
